VivoSeq
Other

Anesthesia Induction

3

Pipeline Programs

9

Active Trials

1

Companies Involved

Anesthesia Induction is an early-stage landscape with 3 programs across 1 company. The most active players are Haisco Pharmaceutical Group Co., Ltd.. 3 therapies are approved.

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

31

clinical trials

Completed17 · 55%
Recruiting7 · 23%
Unknown status5 · 16%
Not yet recruiting2 · 6%

Trial Activity

31 trials

Changes of Cerebral Oxygenation During Anesthesia Induction
Completed··N/A·NCT02687334·33 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)